These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 20529139)
21. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound. Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973 [TBL] [Abstract][Full Text] [Related]
30. Quality of life after radical prostatectomy in Japanese men: a 5-Year follow up study. Namiki S; Ishidoya S; Ito A; Kawamura S; Tochigi T; Saito S; Arai Y Int J Urol; 2009 Jan; 16(1):75-81. PubMed ID: 19054169 [TBL] [Abstract][Full Text] [Related]
31. A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer. Hashine K; Kusuhara Y; Miura N; Shirato A; Sumiyoshi Y; Kataoka M Jpn J Clin Oncol; 2008 Jul; 38(7):480-5. PubMed ID: 18621847 [TBL] [Abstract][Full Text] [Related]
32. Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function. Chen RC; Clark JA; Talcott JA J Clin Oncol; 2009 Aug; 27(24):3916-22. PubMed ID: 19620493 [TBL] [Abstract][Full Text] [Related]
33. [High intensity focused ultrasound combined with endocrine therapy in treating prostate cancer]. Hua LX; Wu HF; Sui YG; Zhang W; Qian LX; Song NH; Zhang JX Zhonghua Nan Ke Xue; 2005 Mar; 11(3):195-7. PubMed ID: 15804111 [TBL] [Abstract][Full Text] [Related]
34. A 3-y prospective study of health-related and disease-specific quality of life in patients with nonmetastatic prostate cancer treated with radical prostatectomy or external beam radiotherapy. Yoshimura K; Arai Y; Ichioka K; Matsui Y; Ogura K; Terai A Prostate Cancer Prostatic Dis; 2004; 7(2):144-51. PubMed ID: 15111981 [TBL] [Abstract][Full Text] [Related]
35. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer. Bradley EB; Bissonette EA; Theodorescu D BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117 [TBL] [Abstract][Full Text] [Related]
36. Salvage laparoscopic extraperitoneal radical prostatectomy after failed high-intensity focused ultrasound and radiotherapy for localized prostate cancer. Stolzenburg JU; Bynens B; Do M; Rabenalt R; Katsakiori PF; Liatsikos E Urology; 2007 Nov; 70(5):956-60. PubMed ID: 17919699 [TBL] [Abstract][Full Text] [Related]
37. Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05. Feigenberg SJ; Lee WR; Desilvio ML; Winter K; Pisansky TM; Bruner DW; Lawton C; Morton G; Baikadi M; Sandler H Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):956-64. PubMed ID: 15989995 [TBL] [Abstract][Full Text] [Related]
38. The effect on erectile function of 103palladium implantation for localized prostate cancer. Ponholzer A; Oismüller R; Somay C; Büchler F; Maier U; Hawliczek R; Rauchenwald M; Madersbacher S BJU Int; 2005 Apr; 95(6):847-50. PubMed ID: 15794796 [TBL] [Abstract][Full Text] [Related]
39. Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer. Lee WR; McQuellon RP; Case LD; deGuzman AF; McCullough DL J Urol; 1999 Aug; 162(2):403-6. PubMed ID: 10411047 [TBL] [Abstract][Full Text] [Related]